Incyte announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor,...
Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, announced meeting the primary endpoint on an interim analysis of...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Pangaea Data, provider of a novel Artificial Intelligence (AI)-driven product for characterizing patients by mapping their journey and disease trajectories in a privacy-preserving and...
Maze Therapeutics, a company translating genetic insights into new precision medicines, to announced new data from an exploratory muscle biopsy cohort of its Phase...
